Dietary fat, cholesterol, and cholic acid affect the histopathologic severity of nonalcoholic steatohepatitis in Sprague-Dawley rats. 2019

Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
Division of Nutrition Science, Graduate School of Human Health Science, University of Nagasaki, Nagayo-cho, Nagasaki, 851-2195, Japan.

Understanding of the pathogenesis of nonalcoholic steatohepatitis (NASH)-associated fibrosis has been hampered by the lack of a comprehensive and physiological small animal model of NASH with fibrosis. Feeding a high-fat and high-cholesterol (HFC) diet supplemented with cholic acid to rats is known to replicate human NASH pathology, and it induces fibrosis earlier than with an HFC diet alone. In the present study, physiological and histopathological observations from 65 Sprague-Dawley (SD) rats fed an HFC diet with or without cholic acid for 9 or 18 weeks in our laboratory between January 2013 and February 2018 were retrospectively reviewed. The liver weight/body weight ratio at the end of the rearing period was higher in rats fed an HFC diet than in rats fed a normal diet in a cholesterol dose-, cholic acid dose-, or rearing period dependent manner. Dietary fat, cholesterol and/or cholic acid and rearing period affected the histopathologic severity of NASH. Overall, 56 (86.2%) of 65 SD rats fed an HFC diet for 9 or 18 weeks developed histopathologically proven NASH. It is noted that the SD rats fed an HFC diet supplemented with 2% (w/w) cholic acid for 18 weeks frequently developed advanced fibrosis, including cirrhosis. Thus, this diet-induced NASH rat model is likely to be a highly reproducible.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008106 Liver Cirrhosis, Experimental Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS. Hepatic Cirrhosis, Experimental,Cirrhoses, Experimental Liver,Cirrhosis, Experimental Liver,Experimental Liver Cirrhoses,Experimental Liver Cirrhosis,Liver Cirrhoses, Experimental,Experimental Hepatic Cirrhosis
D002791 Cholesterol, Dietary Cholesterol present in food, especially in animal products. Dietary Cholesterol
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019826 Cholic Acid A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholbam
D065626 Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. Fatty Liver, Nonalcoholic,NAFLD,Nonalcoholic Fatty Liver Disease,Nonalcoholic Steatohepatitis,Fatty Livers, Nonalcoholic,Liver, Nonalcoholic Fatty,Livers, Nonalcoholic Fatty,Non alcoholic Fatty Liver Disease,Nonalcoholic Fatty Liver,Nonalcoholic Fatty Livers,Nonalcoholic Steatohepatitides,Steatohepatitides, Nonalcoholic,Steatohepatitis, Nonalcoholic

Related Publications

Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
August 2022, International journal of molecular sciences,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
October 2018, Journal of biochemical and molecular toxicology,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
November 2016, International journal of toxicology,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
April 2015, Hepatology research : the official journal of the Japan Society of Hepatology,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
January 1993, Anticancer research,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
April 2020, Toxicology and applied pharmacology,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
February 2017, The Journal of nutritional biochemistry,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
April 2003, Journal of agricultural and food chemistry,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
January 2018, Diabetology & metabolic syndrome,
Ayumi Fukuda, and Marin Sasao, and Eri Asakawa, and Sumire Narita, and Mei Hisano, and Kazuhito Suruga, and Mayuko Ichimura, and Koichi Tsuneyama, and Kazunari Tanaka, and Katsuhisa Omagari
February 2013, Liver international : official journal of the International Association for the Study of the Liver,
Copied contents to your clipboard!